1. Home
  2. GKOS vs CDE Comparison

GKOS vs CDE Comparison

Compare GKOS & CDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • CDE
  • Stock Information
  • Founded
  • GKOS 1998
  • CDE 1928
  • Country
  • GKOS United States
  • CDE United States
  • Employees
  • GKOS N/A
  • CDE N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • CDE Precious Metals
  • Sector
  • GKOS Health Care
  • CDE Basic Materials
  • Exchange
  • GKOS Nasdaq
  • CDE Nasdaq
  • Market Cap
  • GKOS 5.8B
  • CDE 5.7B
  • IPO Year
  • GKOS 2015
  • CDE N/A
  • Fundamental
  • Price
  • GKOS $103.50
  • CDE $9.10
  • Analyst Decision
  • GKOS Strong Buy
  • CDE Strong Buy
  • Analyst Count
  • GKOS 13
  • CDE 4
  • Target Price
  • GKOS $135.15
  • CDE $8.94
  • AVG Volume (30 Days)
  • GKOS 903.0K
  • CDE 14.0M
  • Earning Date
  • GKOS 07-30-2025
  • CDE 08-06-2025
  • Dividend Yield
  • GKOS N/A
  • CDE N/A
  • EPS Growth
  • GKOS N/A
  • CDE N/A
  • EPS
  • GKOS N/A
  • CDE 0.28
  • Revenue
  • GKOS $404,523,000.00
  • CDE $1,201,008,000.00
  • Revenue This Year
  • GKOS $27.88
  • CDE $66.13
  • Revenue Next Year
  • GKOS $27.60
  • CDE $2.80
  • P/E Ratio
  • GKOS N/A
  • CDE $32.34
  • Revenue Growth
  • GKOS 23.92
  • CDE 41.80
  • 52 Week Low
  • GKOS $77.10
  • CDE $4.57
  • 52 Week High
  • GKOS $163.71
  • CDE $9.69
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 61.38
  • CDE 60.67
  • Support Level
  • GKOS $100.92
  • CDE $8.70
  • Resistance Level
  • GKOS $106.52
  • CDE $9.18
  • Average True Range (ATR)
  • GKOS 3.30
  • CDE 0.29
  • MACD
  • GKOS 0.37
  • CDE -0.09
  • Stochastic Oscillator
  • GKOS 71.27
  • CDE 68.75

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About CDE Coeur Mining Inc.

Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada, and Mexico.

Share on Social Networks: